{"disease":{"id":"diabetic-gastroparesis","name":"Diabetic gastroparesis","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"metaclopramide","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Metaclopramide","company_name":"Institute of Liver and Biliary Sciences, India","drug_phase":"discontinued","molecular_target":"Aldehyde oxidase, Myeloperoxidase, Solute carrier family 22 member 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"METOCLOPRAMIDE","company_name":"Hikma","drug_phase":"marketed","molecular_target":"D(3) dopamine receptor","drug_class":"Dopamine-2 Receptor Antagonist","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"metoclopramide-hydrochloride","indication_name":"Diabetic gastroparesis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Reglan","generic_name":"Metoclopramide Hydrochloride","company_name":"Hikma","drug_phase":"marketed","molecular_target":"Acetylcholine receptor sensitization; dopamine antagonism (implied)","drug_class":"Prokinetic agent","quality_score":10,"revenue":null,"mechanism":"Metoclopramide stimulates upper GI tract motility by sensitizing tissues to acetylcholine action."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04028492","title":"Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":992,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":false},{"nct_id":"NCT03680859","title":"Gastroparesis Registry 3","phase":"","overall_status":"COMPLETED","enrollment_count":406,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT05832151","title":"A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":382,"lead_sponsor_name":"CinDome Pharma, Inc.","has_results":false},{"nct_id":"NCT05846802","title":"Gastroparesis Registry 4","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT03544229","title":"A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02025725","title":"Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":205,"lead_sponsor_name":"Evoke Pharma","has_results":true},{"nct_id":"NCT05812339","title":"Body Surface Gastric Mapping to Evaluate Patients With Upper Gastrointestinal Symptoms and Controls","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04303195","title":"A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Neurogastrx, Inc.","has_results":true},{"nct_id":"NCT04661215","title":"Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT05584462","title":"Gastroparesis in type2 Diabetic Patient","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06661668","title":"Laparoscopic Implantation of a Gastric Pacemaker in the Treatment of Gastroparesis","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Evangelic Hospital Kalk Cologne","has_results":false},{"nct_id":"NCT07324785","title":"Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Northern Jiangsu People's Hospital","has_results":false},{"nct_id":"NCT05273788","title":"Thoracic Neuromodulation for Diabetic Gastroparesis","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT06340828","title":"Washed Microbiota Transplantation Alleviates Diabetic Gastrointestinal Motility Disorders: an Efficacy and Safety Study","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"The Second Hospital of Nanjing Medical University","has_results":false},{"nct_id":"NCT05935852","title":"Contrast-enhanced Multispectral Optoacoustic Tomography for Non-invasive Assessment of Diabetic Gastroparesis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"University of Erlangen-Nürnberg Medical School","has_results":false},{"nct_id":"NCT03281577","title":"Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04706832","title":"Thoracic Splanchnic Magnetic Neuromodulation Therapy (ThorS-MagNT) for Grade 3 Diabetic Gastroparesis: Pilot Study","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Augusta University","has_results":false},{"nct_id":"NCT04254549","title":"Rifaximin in Patients With Diabetic Gastroparesis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT03342157","title":"Docusate/Senna for the Treatment of Diabetic Gastroparesis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT04208698","title":"A Scintigraphy Study in Adults With Diabetic Gastroparesis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"CinDome Pharma, Inc.","has_results":true},{"nct_id":"NCT03376399","title":"Potential Benefits of Sleeve Gastrectomy Surgery on Diabetic Gastroparesis Symptoms","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Baylor Research Institute","has_results":false},{"nct_id":"NCT04474990","title":"Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Vanda Pharmaceuticals","has_results":false}],"total":22},"guidelines":[{"drug_id":"metoclopramide-hydrochloride","guideline_body":"FDA label","recommendation":"Relief of symptoms in adults with acute and recurrent diabetic gastroparesis.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}